GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Sanara MedTech Inc.
The stock price of Sanara MedTech, a company specializing in wound healing products, is driven by the success of commercializing its innovative solutions. The chart reflects demand from hospitals and clinics, as well as the results of clinical trials confirming the effectiveness of its technologies.
Share prices of companies in the market segment - Pharma skin
Sanara MedTech (SMTI) specializes in the development and marketing of wound and skin care products designed to improve patient outcomes across a variety of healthcare settings. We classify the company within the Pharmaceuticals/Skin segment. The chart below reflects the dynamics of the advanced skin medical technology sector.
Broad Market Index - GURU.Markets
Sanara MedTech develops and markets wound care and tissue regeneration products. As a component of the GURU.Markets index, it represents the medical technology sector. The chart below represents the entire market. See how Sanara's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
SMTI - Daily change in the company's share price Sanara MedTech Inc.
The daily price change of Sanara MedTech, a wound treatment company, is a measure of its sensitivity to medical innovation. Change_co reflects the volatility inherent in the medical technology sector. This metric is important for formulas on System.GURU.Markets that analyze smaller medical companies.
Daily change in the price of a set of shares in a market segment - Pharma skin
Sanara MedTech Inc. is a company in the medical technology sector. This chart shows high volatility. Comparing it to SMTI, which focuses on wound care, helps assess whether its innovative products make it more or less volatile than the sector.
Daily change in the price of a broad market stock, index - GURU.Markets
Sanara is a medical technology company specializing in wound healing products. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Sanara's stock is responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Sanara MedTech Inc.
For Sanara MedTech Inc., year-over-year performance is a story of growth in the wound care market. Its 12-month market cap growth reflects success in promoting its innovative collagen-based products and other biomaterials, which accelerate healing and are increasingly in demand in hospitals and clinics.
Annual dynamics of market capitalization of the market segment - Pharma skin
Sanara MedTech Inc. is a medical technology company focused on wound healing products. Its growth strategy is based on acquisitions. The chart below shows how its M&A activity and ability to successfully integrate and commercialize new products impact its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sanara, specializing in wound healing products, is a growth story in the medical field. Its stock price is driven not by the economy, but by demand for its innovative products and the insurance benefits system. The chart reflects the potential of this breakthrough technology in the vast chronic wound treatment market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Sanara MedTech Inc.
Sanara, a medical technology company, depends on its product cycle for its value. The monthly fluctuations on the chart reflect sales of its wound healing products and the progress of commercializing new technologies that underpin its long-term growth.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Sanara MedTech develops and markets wound care and skin regeneration products, targeting the surgical and chronic care markets. The company's growth depends on the adoption of its technologies in hospitals and clinics. The pharmaceutical and medical sector chart will highlight general trends that can be used to evaluate Sanara's commercial strategy and product potential.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sanara MedTech specializes in wound healing and skin care products. As a medical technology company, its success depends on clinical adoption and demographic trends such as an aging population. The stock is expected to demonstrate stable growth, less susceptible to overall market fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Sanara MedTech Inc.
Sanara MedTech develops and markets wound healing products, working at the intersection of biotechnology and medical devices. Its weekly stock price reflects the clinical efficacy of its products, hospital purchasing decisions, and overall trends in surgery and patient care.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Companies developing wound healing products, like Sanara MedTech, operate in a growing market driven by an aging population. The graph below shows the overall dynamics of this segment, allowing one to assess how successfully Sanara's go-to-market strategy is outpacing its competitors.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Sanara MedTech offers products for tissue regeneration and wound healing. Its business lies at the intersection of biotechnology and medical devices. The chart below shows how investors assess its growth potential in this niche and how its growth correlates with the broader healthcare market.
Market capitalization of the company, segment and market as a whole
SMTI - Market capitalization of the company Sanara MedTech Inc.
Sanara MedTech's market capitalization chart represents investors' assessment of its wound healing product portfolio. Its dynamics reflect the market's appreciation of its technologies aimed at improving the treatment of chronic wounds and surgical incisions. This growth indicates growing demand for advanced solutions in this area of ββmedicine.
SMTI - Share of the company's market capitalization Sanara MedTech Inc. within the market segment - Pharma skin
Sanara MedTech specializes in wound healing and skin care products. Its market capitalization in the skin pharmaceuticals segment reflects its focus on this important yet often overlooked market. The company's market capitalization reflects the demand for its innovative solutions in hospitals and clinics for treating complex wounds and improving patient outcomes.
Market capitalization of the market segment - Pharma skin
Below is a graph showing the total value of the entire pharmaceutical sector focused on skin care. For Sanara MedTech, which specializes in wound healing products, this line represents a map of medical needs. The graph's growth reflects the aging population and the increasing incidence of chronic diseases requiring advanced wound care solutions.
Market capitalization of all companies included in a broad market index - GURU.Markets
Sanara MedTech develops and markets products for wound care and tissue regeneration. Its market capitalization reflects the value of its healing technologies. Overall, this represents the market share of businesses that help the body recover from injuries and surgeries.
Book value capitalization of the company, segment and market as a whole
SMTI - Book value capitalization of the company Sanara MedTech Inc.
Sanara MedTech develops and markets wound healing products. Its book value is a combination of its financial resources and product portfolio. This includes cash for R&D and commercialization, as well as medical product inventory. How has this capital changed as the business has expanded? The chart below shows.
SMTI - Share of the company's book capitalization Sanara MedTech Inc. within the market segment - Pharma skin
Sanara MedTech Inc. offers wound healing products, and its technologies are backed by a manufacturing and logistics base. The company's balance sheet reflects the value of its manufacturing and distribution capabilities for advanced medical materials. The chart shows the company's share of the physical infrastructure in this niche medical technology segment.
Market segment balance sheet capitalization - Pharma skin
Sanara MedTech, a medical technology company, is a moderately capital-intensive business. It requires R&D capacity and control over the production of its wound care products. The BCap_Seg chart for the medical equipment sector shows that innovation requires a material base.
Book value of all companies included in the broad market index - GURU.Markets
Sanara MedTech's book value is its portfolio of patents and wound healing and skin care products, as well as the commercial infrastructure to market them. The company's assets represent its intellectual and commercial capital. The chart below shows how this specialized medical business compares in terms of asset size.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Sanara MedTech Inc.
Sanara MedTech's balance sheet is its wound care product portfolio. The market premium reflects confidence in its growth strategy and ability to successfully launch new medical products. The chart is an assessment of its commercial potential.
Market to book capitalization ratio in a market segment - Pharma skin
Sanara MedTech is a company focused on wound healing products, a growing segment of the medical industry. The chart below shows how investors view its product portfolio and growth strategy in this specialized market, which requires clinically proven efficacy.
Market to book capitalization ratio for the market as a whole
Sanara MedTech develops and markets wound healing products. Its value is determined by its product portfolio and technologies. Its market valuation reflects its growth potential in a large and important medical market. The chart compares this valuation to its assets.
Debts of the company, segment and market as a whole
SMTI - Company debts Sanara MedTech Inc.
Sanara MedTech, a company focused on wound healing products, is using capital to commercialize its portfolio and acquire new technologies. This chart shows how the company is funding its growth in a niche medical device market, aiming to offer comprehensive solutions for treating complex wounds and improving patient outcomes.
Market segment debts - Pharma skin
Sanara MedTech is a company developing and commercializing wound healing products. In the medical technology industry, bringing products to market requires investment in clinical data and sales. This chart shows the company's chosen financial strategy for growth: organic revenue-driven or external capital.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Sanara MedTech Inc.
Sanara MedTech specializes in wound healing products, a key segment of the medical market. Debt can be raised for clinical research, marketing, or acquisition of new technologies. This chart shows how the company finances its growth. It provides insight into its financial strategy and the risks involved in expanding its market share in the medical technology sector.
Market segment debt to market segment book capitalization - Pharma skin
Sanara MedTech focuses on the development and commercialization of wound healing and skin care products. This segment of the medical market is growing due to the aging population. The chart shows the overall debt burden in the sector, providing context for assessing how Sanara finances its product launches.
Debt to book value of all companies in the market
Sanara MedTech develops wound healing products at the intersection of biotech and medical devices. This chart, showing the market's overall debt load, provides important context. It helps understand how the company finances its growthβthrough operating cash flow or debtβand the sustainability of its strategy in the healthcare sector.
P/E of the company, segment and market as a whole
P/E - Sanara MedTech Inc.
Sanara MedTech develops and markets wound care and tissue regeneration products. This chart shows how investors value its medical technologies. The trend reflects the demand for advanced solutions for chronic wound treatment, which is a significant challenge in healthcare, especially in the context of an aging population.
P/E of the market segment - Pharma skin
Sanara MedTech operates in the advanced wound care market. This chart shows the average valuation for the medical device sector. It helps understand how investors view its product portfolio and growth strategy in this competitive but rapidly growing market.
P/E of the market as a whole
Sanara MedTech Inc. is a company focused on the development and commercialization of innovative products for wound care and tissue regeneration. This chart reflects the overall sentiment in the medical technology sector. It helps understand whether SMTI's valuation reflects confidence in its product portfolio or is driven by broader healthcare industry trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Sanara MedTech Inc.
Sanara MedTech develops and markets products for wound care and tissue regeneration. The company's future profitability depends on the implementation of its innovative solutions in hospitals and clinics. This chart reflects market expectations for the growth of the advanced wound care sector and the commercial success of its portfolio.
Future (projected) P/E of the market segment - Pharma skin
Sanara MedTech develops and markets wound care and tissue regeneration products for use in hospitals and clinics. This chart reflects the company's future profitability expectations, demonstrating analyst confidence in the effectiveness of its products and its ability to capture market share in advanced wound care.
Future (projected) P/E of the market as a whole
Sanara MedTech develops and markets wound healing and skin care products. This is a specialized healthcare segment. This graph of overall market expectations shows that companies focused on specific medical needs can demonstrate stable growth regardless of overall market dynamics.
Profit of the company, segment and market as a whole
Company profit Sanara MedTech Inc.
Sanara MedTech develops and markets wound healing and skin care products. This chart shows its efforts to commercialize its medical technologies. Revenue growth will depend on the successful implementation of its products in hospitals and clinics, as well as portfolio expansion through new developments or acquisitions.
Profit of companies in the market segment - Pharma skin
Sanara MedTech is a company specializing in the development and sale of wound treatment and skin care products. Its products are used in hospitals and clinics. The company's profitability depends on the implementation of its technologies in medical practice and is part of a large and growing medical technology market.
Overall market profit
Sanara MedTech is a company that supplies innovative wound healing and skin care products. Demand for its products depends on the volume of surgical procedures and patient needs. This dynamic, reflecting the state of the economy, impacts hospital budgets and overall activity in the healthcare sector, which are Sanara's key markets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Sanara MedTech Inc.
Sanara MedTech develops and markets products for wound care and tissue regeneration. This chart shows analysts' expectations for future revenue. The forecast depends on sales growth in hospitals and clinics, as well as the success of new products aimed at improving the healing of complex wounds and skin lesions.
Future (predicted) profit of companies in the market segment - Pharma skin
Sanara MedTech develops and markets wound healing and skin care products. The profitability forecasts for this sector, shown in the graph, highlight demand driven by an aging population and rising rates of chronic diseases. This chart helps assess how Sanara's innovative products can improve patient outcomes.
Future (predicted) profit of the market as a whole
Sanara MedTech is a company specializing in the development and sale of wound healing products. Demand for its products comes from hospitals and clinics and is relatively stable. However, economic growth, reflected in the graph, is improving the financial health of medical institutions, allowing them to utilize more modern and effective treatments.
P/S of the company, segment and market as a whole
P/S - Sanara MedTech Inc.
Sanara MedTech develops and markets wound healing and skin care products. This chart shows how investors view the revenue of this niche medical device company. This growth may reflect the successful adoption of its products in hospitals and clinics, as well as potential for product line expansion.
P/S market segment - Pharma skin
Sanara MedTech is a company focused on the development and commercialization of wound healing and skin care products. This chart shows the average revenue estimate in the pharmaceutical sector. It helps understand how the market perceives the potential of Sanara's products in the large and growing tissue regeneration market.
P/S of the market as a whole
Sanara MedTech specializes in the development and sale of wound treatment and skin care products. The company's products are used in hospitals, clinics, and home care. This chart compares how the market values ββthe company's revenue in the niche medical technology segment with overall market sentiment.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Sanara MedTech Inc.
Sanara MedTech develops and markets wound care and tissue regeneration products. This chart shows how investors estimate its future revenue. This valuation is a bet on growing demand for its innovative solutions in hospitals and clinics for the treatment of chronic wounds.
Future (projected) P/S of the market segment - Pharma skin
Sanara MedTech develops and markets wound care and tissue regeneration products. This chart compares market expectations for its future revenue with those of other skin care pharmaceutical companies. This valuation reflects investors' confidence in its product portfolio and its ability to capture market share in chronic wound treatment, which is growing due to an aging population.
Future (projected) P/S of the market as a whole
Sanara MedTech is a company specializing in the development and sale of wound healing products. Demand for its products is driven by the needs of the healthcare system. This graph of overall market expectations is less important to Sanara than demographic trends (aging population, diabetes) and the company's ability to bring effective medical solutions to market.
Sales of the company, segment and market as a whole
Company sales Sanara MedTech Inc.
This chart shows the revenue of Sanara MedTech, a company focused on wound care and tissue regeneration products. Revenue is generated from sales of innovative dressings and other products for hospitals and clinics. Revenue growth reflects the demand for advanced solutions for the treatment of complex and chronic wounds, a significant challenge in healthcare.
Sales of companies in the market segment - Pharma skin
Sanara MedTech is a company focused on the development and commercialization of wound care and tissue regeneration products. Its goal is to improve treatment outcomes for patients with chronic wounds. This graph shows revenue in the skin pharmaceuticals sector. It reflects the aging population and the rise in chronic diseases such as diabetes, increasing the need for advanced wound healing solutions.
Overall market sales
Sanara MedTech develops and commercializes wound healing and skin care products. Demand for its products comes from hospitals and clinics. The overall economic situation, reflected in this chart, impacts the budgets of these medical institutions and their ability to purchase innovative, but potentially more expensive, treatments for patients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Sanara MedTech Inc.
Sanara MedTech specializes in the development and sale of wound and skin care products designed to improve patient outcomes. This revenue projection chart reflects the demand for advanced medical technologies. This growth is driven by expectations for increased use of its innovative products in hospitals and wound care clinics.
Future (projected) sales of companies in the market segment - Pharma skin
Sanara MedTech is a company specializing in the development and sale of wound care and skin regeneration products. Its solutions are designed for use in hospitals, clinics, and home care. This chart shows projected revenue for the entire skin pharmaceutical sector, reflecting the demand for advanced solutions for the treatment of chronic wounds and burns.
Future (projected) sales of the market as a whole
Sanara MedTech develops and markets wound care products. Demand for its products is driven by the needs of the healthcare system. An aging population and the prevalence of chronic diseases such as diabetes are long-term drivers. A stable economic environment ensures funding for hospitals, its primary clients.
Marginality of the company, segment and market as a whole
Company marginality Sanara MedTech Inc.
Sanara MedTech focuses on developing and selling products for regenerative medicine and wound care. Profitability in this field depends on innovation and market access. The chart shows how successfully the company sells its products to hospitals and clinics, and how this translates into bottom-line profit after R&D and marketing expenses.
Market segment marginality - Pharma skin
Sanara MedTech develops and markets wound care and tissue regeneration products for healthcare providers. This chart shows the profitability of its business in the medical technology sector. A focus on innovative products that improve patient outcomes allows the company to carve out a niche and maintain profitability above the industry average.
Market marginality as a whole
Sanara MedTech develops and markets wound healing and skin care products. Demand for their products is driven by healthcare system needs, not by the general economic cycles shown in this graph. An aging population and the rise of chronic diseases such as diabetes are increasing the need for effective wound treatments.
Employees in the company, segment and market as a whole
Number of employees in the company Sanara MedTech Inc.
Sanara MedTech is a company focused on the development and sale of tissue regeneration and wound care products. This chart shows the growing commercial team. The increase in staff is directly related to the expansion of the product portfolio, both through in-house development and distribution agreements.
Share of the company's employees Sanara MedTech Inc. within the market segment - Pharma skin
Sanara MedTech specializes in wound care and skin care products. Its market success depends on a team of researchers developing new products and a dedicated sales team serving medical institutions. This chart illustrates its scale within the medical technology niche, reflecting its share of the talent pool in this field.
Number of employees in the market segment - Pharma skin
Sanara MedTech develops and markets wound care products for use in hospitals and clinics. This chart shows growth in the niche medical technology segment. The company's success and the growth of its sales team depend on demonstrating the clinical and cost-effectiveness of its products, allowing them to gain market share in the conservative medical market.
Number of employees in the market as a whole
Sanara MedTech is a company focused on developing and selling wound healing and skin care products. Its growth reflects the demand for advanced medical solutions in this field. This employment chart shows how specialized medical companies are creating jobs to meet the needs of the healthcare system and an aging population.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Sanara MedTech Inc. (SMTI)
Sanara MedTech specializes in the development and sale of wound healing products used in surgery and for the treatment of chronic ulcers. It is a niche medical business. This chart shows how the market perceives the potential of the company's products. A high cost per employee may indicate high product margins and the effectiveness of the sales team.
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Sanara MedTech is a company specializing in the development and sale of wound healing and skin care products. In the medical technology sector, this metric reflects the value of their product portfolio. It allows one to assess how successfully a company commercializes its developments, creating a high market value per employee.
Market capitalization per employee (in thousands of dollars) for the overall market
Sanara MedTech develops and markets wound healing products. This metric reflects its business in a niche medical field. Value is created through innovative products that can improve treatment outcomes. The market evaluates the clinical and commercial potential of its portfolio, which is being developed by a small team.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Sanara MedTech Inc. (SMTI)
Sanara MedTech offers medical technologies for wound and skin care. Their business is selling specialized medical products. This chart shows the demand for their products and the profit margins they generate. High profit per employee in this sector is a sign of strong R&D and an effective sales team serving hospitals.
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Sanara MedTech specializes in selling advanced wound and skin care products to the US medical market. It's a sales-driven business, which is a direct indicator of the performance of their sales team and the profitability of their specialized medical products compared to industry peers.
Profit per employee (in thousands of dollars) for the market as a whole
Sanara MedTech specializes in wound treatment and healing products. This is the medical device market. Revenue per employee here depends on the effectiveness of R&D (creating new products) and the sales team that must convince hospitals and doctors to use their products. This graph shows the margins of their niche medical business.
Sales to employees of the company, segment and market as a whole
Sales per company employee Sanara MedTech Inc. (SMTI)
Sanara MedTech is a company focused on developing and selling wound healing products. This chart shows how they are commercializing their medical technologies. The growth in revenue per employee reflects successful sales of their products to hospitals and clinics, as well as the expansion of their portfolio with new developments.
Sales per employee in the market segment - Pharma skin
Sanara MedTech (SMTI) is a company specializing in medical technologies for wound treatment and skin care, offering biotech products. This chart shows how much revenue each employee generates from sales of their medical devices. It's an indicator of the effectiveness of their sales team and the value of their products in the wound care niche.
Sales per employee for the market as a whole
Sanara MedTech (SMTI) is a company focused on developing and selling wound healing products (surgery, chronic wounds). It's a MedTech business. This metric reflects the productivity of their sales team. Growth here means their products are increasingly being used in hospitals, generating revenue per sales representative.
Short shares by company, segment and market as a whole
Shares shorted by company Sanara MedTech Inc. (SMTI)
Sanara MedTech specializes in wound treatment and healing products. This chart measures bearish bets. Bearish bets may doubt the small company's ability to compete with medtech giants or that its products will be widely adopted by hospitals and clinics where established brands are strong.
Shares shorted by market segment - Pharma skin
Sanara MedTech specializes in wound care and skin care products, supplying them to hospitals and clinics. This figure reflects skepticism. "Short" here is a bet that their products won't compete with giants like 3M or that their sales strategy is ineffective.
Shares shorted by the overall market
Sanara MedTech focuses on wound healing and skin care products, serving hospitals and clinics. This is a niche healthcare segment. This chart reflects the overall market pessimism. While healthcare is generally resilient, when the market is in turmoil, investors may fear a decline in elective surgeries, which could impact demand for the company's products.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Sanara MedTech Inc. (SMTI)
Sanara MedTech (SMTI) is a wound healing technology company. They sell collagen-based products and other solutions for chronic wounds (such as diabetic ulcers). This chart measures momentum. It shows "overbought" (above 70) amid strong revenue growth or "oversold" (below 30) amid competitive concerns.
RSI 14 Market Segment - Pharma skin
Sanara (SMTI) is a medtech company focused on *wound treatment* (biosurgery, skin substitutes). The RSI_14_Seg for "Pharma skin" (biotech) shows the overall sentiment. The chart helps us understand: is SMTI's volatility a reaction to its products, or is the entire sector overheated (or oversold)?
RSI 14 for the overall market
Sanara MedTech (SMTI) produces wound care products. This chart shows that its business is "defensive." Demand for chronic wound care (like diabetes) isn't affected by euphoria or panic. During periods of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SMTI (Sanara MedTech Inc.)
Sanara MedTech (SMTI) is a company specializing in innovative wound treatment and healing products (skin grafts, ointments). This chart shows the average 12-month forecast. It reflects analyst expectations for hospital sales growth and surgeon adoption of its products.
The difference between the consensus estimate and the actual stock price SMTI (Sanara MedTech Inc.)
Sanara MedTech is a company focused on advanced wound care. They supply hospitals with a portfolio of products (gels, collagens, and skin substitutes) that help heal complex surgical and chronic (diabetic) wounds. This chart shows how analysts assess their niche commercial strategy and growth in the regenerative medicine sector.
Analyst consensus forecast for stock prices by market segment - Pharma skin
Sanara MedTech is a company focused on wound healing technologies. It sells innovative products for surgical and chronic wound care. This chart shows general expectations for the skin pharma sector. It reflects whether experts believe demand for advanced surgical treatments will grow.
Analysts' consensus forecast for the overall market share price
Sanara MedTech (SMTI) is a company focused on treating complex wounds. They offer innovative skin and tissue regeneration products, helping to heal chronic ulcers and surgical wounds. This chart shows the general sentiment of experts. It reflects the extent to which analysts believe healthcare spending in niche but expensive segments will remain stable.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Sanara MedTech Inc.
Sanara MedTech is a medical technology company in the wound healing niche. They offer a portfolio of products (collagen, bio-matrices) that help treat complex chronic wounds (e.g., diabetic ulcers). This chart is a barometer of their growth. It likely reflects their ability to increase their share of the surgeon's portfolio and their rapid sales growth in this high-margin segment.
AKIMA Market Segment Index - Pharma skin
Sanara MedTech (SMTI) is a medtech innovator focused on chronic wound treatment (like Organogenesis); the company develops and markets a portfolio of innovative tissue repair products. This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does this niche (wound treatment) model (SMTI) differentiate itself from the average pharmaceutical company?
The AKIM Index for the overall market
Sanara MedTech develops and markets wound healing products and surgical technologies. It grows through acquisitions. This chart, reflecting the market average, provides context. It helps assess how this niche healthcare player, which is consolidating its market, stacks up against overall macroeconomic trends.